Your browser doesn't support javascript.
loading
Delivering information about medication assisted treatment to individuals who misuse opioids through a mobile app: a pilot study.
Cavazos-Rehg, Patricia A; Krauss, Melissa J; Costello, Shaina J; Ramsey, Alex T; Petkas, Demetrie; Gunderson, Sean; Bierut, Laura J; Marsch, Lisa A.
Afiliação
  • Cavazos-Rehg PA; Department of Psychiatry, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO, USA.
  • Krauss MJ; Department of Psychiatry, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO, USA.
  • Costello SJ; Department of Psychiatry, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO, USA.
  • Ramsey AT; Department of Psychiatry, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO, USA.
  • Petkas D; iTether Technologies, 1300 East Missouri Avenue, Suite 100, Phoenix, AZ,USA.
  • Gunderson S; iTether Technologies, 1300 East Missouri Avenue, Suite 100, Phoenix, AZ,USA.
  • Bierut LJ; Department of Psychiatry, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO, USA.
  • Marsch LA; Department of Psychiatry, Dartmouth College, Hanover, NH, USA.
J Public Health (Oxf) ; 42(1): 149-154, 2020 02 28.
Article em En | MEDLINE | ID: mdl-30445639
ABSTRACT

BACKGROUND:

Digital therapeutic tools (e.g. mobile applications) can be accessible, low-cost interventions that counter misconceptions about medication assisted treatment (MAT) and/or improve deficits in MAT knowledge that are common barriers to treatment entry among individuals with opioid dependence. The purpose of this pilot study was to examine the preliminary effectiveness of a mobile application, 'uMAT-R', that includes health information about OUD recovery supported by science and MAT benefits.

METHODS:

Twenty-six adult participants with OUD recruited via social media completed all modules and pre/post-assessments within uMAT-R. McNemar's test was used to compare interest in treatment before and after completing the app, and paired t tests were used to compare MAT attitude scores before and after completing the modules within uMAT-R.

RESULTS:

Before viewing uMAT-R, 32% agreed/strongly agreed that they were interested in starting treatment to recover from opioid misuse, compared to 48% after completing uMAT-R. The average scores on the MAT attitudes scale and its Aid to Behavior Change subscale improved from before to after viewing uMAT-R. Among the participants, 88% felt that uMAT-R would be useful to consult when making decisions about recovery.

CONCLUSIONS:

Our encouraging pilot findings support the use of uMAT-R to help address the current opioid epidemic.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Buprenorfina / Aplicativos Móveis Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Buprenorfina / Aplicativos Móveis Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article